| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $156.8M | +8.3% |
| Cost of Revenue | $39.4M | +5.4% |
| Gross Profit | $117.4M | +9.3% |
| R&D Expense | $56.6M | +9.9% |
| SG&A Expense | $48.9M | +19.2% |
| Operating Income | -$48.1M | +22.0% |
| Pre-tax Income | -$43.6M | +21.3% |
| Income Tax | $743K | +123.8% |
| Net Income | -$44.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.7M | -62.8% |
| Short-term Investments | $94.9M | +24.3% |
| Accounts Receivable | $25.6M | +10.8% |
| Current Assets | $153.0M | -2.5% |
| Total Assets | $173.6M | -3.7% |
| Current Liabilities | $40.4M | +57.3% |
| Total Liabilities | $45.5M | +38.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.9M | -70.7% |
| Capital Expenditures | $3.1M | +9.8% |
| Investing Cash Flow | -$18.2M | +76.7% |
| Financing Cash Flow | $16K | +100.1% |
| Free Cash Flow | -$18.0M | -56.0% |
| +20.4% |
| EPS (Basic) | -$0.72 | +22.6% |
| EPS (Diluted) | -$0.72 | +22.6% |
| Stockholders' Equity |
| $128.1M |
| -13.2% |